CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
about
Unexpected mutations after CRISPR–Cas9 editing in vivoCRISPR-Cas Genome Surgery in Ophthalmology.Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes.Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.In vivo versus ex vivo CRISPR therapies for retinal dystrophy.Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.Correction of Monogenic and Common Retinal Disorders with Gene Therapy.CRISPR applications in ophthalmologic genome surgery.Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.Delivery technologies for genome editing.Applications of CRISPR/Cas9 in retinal degenerative diseasesGene therapy approaches for prevention of retinal degeneration in Usher syndrome.Repair of the TGFBI gene in human corneal keratocytes derived from a granular corneal dystrophy patient via CRISPR/Cas9-induced homology-directed repair.CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology.CRISPR-mediated Ophthalmic Genome Surgery.CRISPR in the Retina: Evaluation of Future Potential.Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.Genome Surgery and Gene Therapy in Retinal Disorders.Gene therapy and genome surgery in the retina.Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases.CRISPR/Cas9 genome surgery for retinal diseasesIn Vivo Genome Editing as a Therapeutic Approach
P2860
Q30130913-C471E161-4956-4B4D-ADC9-EC5182284683Q33745403-86E1480B-BAF2-4C98-ACAD-45BD4A9F867DQ34551100-AD1D591E-8393-4E7F-A57A-F17F29B418C6Q37452246-30FBB876-74D6-4D3D-BAF7-A54CE330B154Q37621868-F7C365F9-B05C-424F-A111-35A37CD747C0Q37636830-C116CE24-FC3F-48A9-8861-AEB8EDF4B128Q37676230-7D459CBE-C4D1-4B46-88CA-AB24830F708EQ38763768-87C16F9D-3F33-4A49-81A6-A790A70FEB51Q38767261-31AE238E-E2DD-43E1-B719-D841284D8751Q39197557-516473BC-2B35-440C-B106-CB1B079F5280Q39306038-53DDEF7D-EEDE-4DA6-B20F-E4384367214DQ45863379-B158E5A4-0AFF-4E70-90C9-137AEF87BE5CQ47108359-D0B18FB0-41BC-4723-8675-A1797B94ABC3Q47300454-EBDC9F68-64D5-47ED-82F3-5554D56C5AE4Q47612258-89E4ABAB-3BEA-460F-811E-18EABEEBDC23Q47843961-DE7DF9F2-3A7B-416D-972E-5BCC56E1B102Q52366335-43FD432E-D7FC-4EE4-ACA5-29F4267586DAQ52429662-AAC257FA-E40F-4FAB-BF0E-DAF99E86181AQ54977409-A8A6F39E-BC00-4346-9E5C-F90562480833Q55000684-425D8EE6-A2E4-4B9B-8038-9D6FBCAB1CC7Q55078786-132F5ABE-34D2-4DEF-A0DA-0D837CF12511Q55180016-5E92CE5C-B418-41E1-94F0-B0D464256432Q57171979-C5149392-B952-4518-8A89-F42DD4B63531Q58745391-4BA4F693-FB4E-4D11-9686-6CC4415E489B
P2860
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
@en
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
@nl
type
label
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
@en
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
@nl
prefLabel
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
@en
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
@nl
P2093
P2860
P356
P1433
P1476
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
@en
P2093
Alexander G Bassuk
Chyuan-Sheng Lin
Lijuan Zhang
Sally Justus
Stephen H Tsang
Ting-Ting Lee
Vinit B Mahajan
Wen-Hsuan Wu
Yi-Ting Tsai
P2860
P304
P356
10.1038/MT.2016.107
P577
2016-05-20T00:00:00Z